<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Lynn Rochester | Roman Tremmel</title><link>https://www.romantremmel.de/author/lynn-rochester/</link><atom:link href="https://www.romantremmel.de/author/lynn-rochester/index.xml" rel="self" type="application/rss+xml"/><description>Lynn Rochester</description><generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><copyright>@ 2021 Roman Tremmel</copyright><lastBuildDate>Thu, 06 Jan 2022 00:00:00 +0000</lastBuildDate><image><url>https://www.romantremmel.de/media/icon_hud2621e53b423f5d319e44a139e5a303a_27453_512x512_fill_lanczos_center_2.png</url><title>Lynn Rochester</title><link>https://www.romantremmel.de/author/lynn-rochester/</link></image><item><title>Mobility endpoints in marketing authorisation of drugs: what gets the European medicines agency moving?</title><link>https://www.romantremmel.de/publication/2022_35077553/2022_35077553/</link><pubDate>Thu, 06 Jan 2022 00:00:00 +0000</pubDate><guid>https://www.romantremmel.de/publication/2022_35077553/2022_35077553/</guid><description/></item></channel></rss>